(600055)"Beijing Wandong Medical Technology Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600055 · · 11 pages · Chinese
Summary by 6ix AI
The report includes significant financial metrics such as total assets and equity attributable to shareholders, along with changes and reasons for these figures. It also provides insights into non-recurring gains and losses, as well as a summary of the company's financial statements for the quarter. The report is not audited and emphasizes the accuracy and completeness of the financial information presented.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Wandong Medical Technology Co., Ltd. on 6ix
Earlier from Beijing Wandong Medical Technology
- (600055)"Beijing Wandong Medical Technology Co., Ltd."Announcement on Obtaining Medical Device Registration Certificate
- (600055)"Beijing Wandong Medical Technology Co., Ltd."Announcement on Progress of the M&A Fund Invested in by the Company
- Announcement on Progress in Using Idle Raised Funds and Self-owned Funds for Cash Management by the Company and Its Subsidiary
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
Follow Beijing Wandong Medical Technology into a list and get an email when it puts out news.
Follow Beijing Wandong Medical Technology